Ying Chan

Ying Kai Chan is a highly accomplished individual with an exceptional educational background and extensive experience in the field of Microbiology, Immunobiology, and Translational Medicine. Chan earned a Doctor of Philosophy (Ph.D.) from Harvard Medical School, focusing on Microbiology and Immunobiology, with a specialization in Translational Medicine. Prior to this, Chan pursued a Master's Degree in Biological Sciences from Stanford University and a Bachelor's Degree in Neuroscience from Washington University in St. Louis.

Throughout Chan's professional journey, they have been associated with renowned institutions and organizations. Chan served as a Blavatnik Fellow in Life Science Entrepreneurship at Harvard Business School, showcasing their skills in combining life sciences with business acumen. Additionally, Chan contributed as a Visiting Scholar at the prestigious Wyss Institute for Biologically Inspired Engineering, displaying their interest in cutting-edge research and innovation. Moreover, Chan played pivotal roles at Ally Therapeutics, where they were a Co-Founder, Chief Scientific Officer, and Advisor, demonstrating exceptional leadership and entrepreneurial abilities. Chan also excelled in academia as a former Principal Investigator and Research Associate at Harvard Medical School, highlighting their expertise in research and scientific exploration.